维普中文期刊产品整合服务
1篇 您的检索式:作者名="Mahdi Sheikh"
    题名 作者 年代 出处 被引量
1Comparison of efficacy of folic acid and silymarin in the management of antiepileptic drug induced liver injury:a randomized clinical trial显示文摘BACKGROUND: Liver injury associated with antiepileptic drugs accounts for a large proportion of drug-induced liver injuries(DILI) in children. Although withdrawal of the causative agent is the only proved treatment for DILI, in some clinical situations it is not possible. Recent studies have reported promising results of using hepatoprotective drugs with antioxidant actions for the management of DILI. This study aimed to evaluate the efficacy of folic acid versus silymarin treatment in relation to decreasing liver enzymes in patients with DILI due to antiepileptic therapy.METHODS: This randomized, open-label, clinical trial evaluated 55 children with epilepsy who were on antiepileptic treatment and experienced DILI. The children were randomized to receive either silymarin(5 mg/kg per day) or folic acid(1 mg per day) for one month and were followed up for three months.RESULTS: Liver enzymes significantly decreased in both groups. The decrease trend in alanine aminotransferase(ALT) and aspartate aminotransferase(AST) were stronger in the folic acid group compared to silymarin group(P=0.04 and P=0.007, respectively). At the end of the study patients in the folic acid group had significantly lower ALT(P=0.04), AST(P=0.02), and gamma-glutamyl transferase(GGT)(P<0.001) levels and also higher percentage of normal ALT(30.7% vs 3.4%, P=0.009) and AST(42.3% vs 0%, P<0.001), and GGT(23.1% vs 0%, P=0.008) values compared to the patients in the silymarin group. No rebound elevations in ALT, AST and GGT levels or adverse reactions were noted in neither of the study groups.CONCLUSION: Although both treatments were safe and effective in decreasing liver enzymes, folic acid seems to be superior to silymarin in the management of DILI.Masoumeh Asgarshirazi Mamak Shariat Mahdi Sheikh 2017Hepatobiliary & Pancreatic Diseases International2017,16,3:2
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费